NICE says there is “no direct evidence” that the drug is better than existing treatment

Gilead says the study was underpowered and so statistically meaningful conclusions could not be drawn

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Updated Date: Thu, 16 Apr 2020 00:00:00 EDT

Doctors treating patients with known or suspected covid-19 should be vigilant for signs of acute myocardial injury, a […]

Deaths from malaria in sub-Saharan Africa could return to levels last seen 20 years ago because of severe […]

The UK government has launched a nationwide surveillance study to track the prevalence of infection with SARS-CoV-2 in […]